A. Coilly

发表

FABP4 and MMP9 levels identified as predictive factors for poor prognosis in patients with nonalcoholic fatty liver using data mining approaches and gene expression analysis

D. Samuel, A. Coilly, C. Desterke, 2019, Scientific Reports.

Portopulmonary hypertension in the current era of pulmonary hypertension management.

M. Humbert, M. Fertin, N. Lamblin, 2020, Journal of hepatology.

Management of HCV Infection After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2019, Evidence-based Gastroenterology and Hepatology 4e.

Interferon-Free Hepatitis C Treatment before and after Liver Transplantation: The Role of HCV Drug Resistance

D. Samuel, B. Roche, A. Coilly, 2015, Viruses.

Long term results of liver transplantation for alpha-1 antitrypsin deficiency.

D. Samuel, J. Dumortier, O. Guillaud, 2020, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Hepatitis B virus reactivation in transplant patients treated for hepatitis C recurrence: Prophylaxis makes the difference.

V. de Lédinghen, D. Samuel, J. Dumortier, 2019, Journal of hepatology.

Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, JHEP reports : innovation in hepatology.

ELITA consensus statements on the use of DAAs in liver transplant candidates and recipients.

T. Berg, I. Colle, S. Khoo, 2017, Journal of hepatology.

Advanced epithelioid hemangioendothelioma of the liver: could lenvatinib offer a bridge treatment to liver transplantation?

D. Samuel, A. Coilly, C. Guettier, 2022, Therapeutic advances in medical oncology.

Safety of sofosbuvir‐based regimens after liver transplantation: longitudinal assessment of renal function in the prospective ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Alimentary pharmacology & therapeutics.

Sofosbuvir compassionate use program for patients with severe recurrent hepatitis C after liver transplantation

R. Fontana, X. Forns, T. Baumert, 2015, Hepatology.

Optimal Management of HCV Transplant Patients

D. Samuel, B. Roche, A. Coilly, 2014, Current Hepatology Reports.

Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Optimum timing of treatment for hepatitis C infection relative to liver transplantation.

D. Samuel, B. Roche, A. Coilly, 2016, The lancet. Gastroenterology & hepatology.

Prospective validation of transient elastography for staging liver fibrosis in patients undergoing hepatectomy and liver transplantation.

D. Samuel, E. Vibert, A. Coilly, 2017, Journal of hepatology.

Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft

D. Samuel, G. Peytavin, L. Bonhomme-Faivre, 2013, AIDS.

Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort

V. de Lédinghen, J. Zucman‐Rossi, T. Asselah, 2022, Journal of Cannabis Research.

Long‐term outcome in liver transplantation candidates with portopulmonary hypertension

M. Humbert, D. Samuel, F. Durand, 2017, Hepatology.

Twenty-year protocol liver biopsies: Invasive but useful for the management of liver recipients.

D. Samuel, E. Ballot, F. Saliba, 2012, Journal of hepatology.

Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium.

D. Wendum, C. Corpechot, R. Poupon, 2009, Gastroenterology.

Current management and perspectives for HCV recurrence after liver transplantation

D. Samuel, B. Roche, A. Coilly, 2013, Liver international : official journal of the International Association for the Study of the Liver.

Direct-Acting Antiviral Medications for Hepatitis C Virus Infection and Pulmonary Arterial Hypertension.

M. Humbert, D. Samuel, X. Jaïs, 2016, Chest.

Location and allocation: Inequity of access to liver transplantation for patients with severe acute‐on‐chronic liver failure in Europe

P. Cortesi, R. Fumagalli, K. Zieniewicz, 2022, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Impact of DSA and immunosuppression minimization on rejection, graft, and patient survival after simultaneous liver–kidney transplantation

F. Saliba, A. Durrbach, A. Coilly, 2022, Frontiers in Medicine.

News and challenges in the treatment of hepatitis C in liver transplantation

D. Samuel, B. Roche, A. Coilly, 2016, Liver international (Print).

Incidental finding of elevated pulmonary arterial pressures during liver transplantation and postoperative pulmonary complications

M. Humbert, D. Samuel, L. Savale, 2022, BMC Anesthesiology.

Protective Role of Tacrolimus, Deleterious Role of Age and Comorbidities in Liver Transplant Recipients With Covid-19: Results From the ELITA/ELTR Multi-center European Study

P. Cortesi, C. Fondevila, S. Conti, 2020, Gastroenterology.

Time to Conversion to an Everolimus‐Based Regimen: Renal Outcomes in Liver Transplant Recipients From the EVEROLIVER Registry

D. Samuel, J. Dumortier, O. Guillaud, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Multicenter Experience with Boceprevir or Telaprevir to Treat Hepatitis C Recurrence after Liver Transplantation: When Present Becomes Past, What Lessons for Future?

V. de Lédinghen, D. Samuel, J. Dumortier, 2015, PloS one.

Liver transplantation for NAFLD cirrhosis: Age and recent coronary angioplasty are major determinants of survival

D. Samuel, K. Boudjema, J. Gugenheim, 2022, Liver international : official journal of the International Association for the Study of the Liver.

Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis

V. de Lédinghen, T. Asselah, D. Thabut, 2021, BMC Infectious Diseases.

Microsporidiosis after liver transplantation: A French nationwide retrospective study

J. Dumortier, C. Duvoux, N. Kamar, 2021, Transplant infectious disease : an official journal of the Transplantation Society.

Ribavirin for chronic hepatitis E virus infection in transplant recipients.

J. Dumortier, L. Rostaing, J. Izopet, 2014, The New England journal of medicine.

Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.

D. Samuel, A. Coilly, 2016, Journal of hepatology.

Clinical Added Value of SARS-CoV-2 Antigen Detection in Blood Samples

T. Naas, C. Vauloup-Fellous, N. Anguel, 2022, Diagnostics.

Histologic Findings Predictive of a Diagnosis of De novo Autoimmune Hepatitis After Liver Transplantation in Adults

D. Samuel, F. Saliba, A. Coilly, 2013, Transplantation.

Efficacy of Sofosbuvir and Daclatasvir in Patients With Fibrosing Cholestatic Hepatitis C After Liver Transplantation.

J. Dumortier, F. Durand, N. Kamar, 2015, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Nodular Regenerative Hyperplasia Is Not a Rare Condition After Liver Transplantation: Incidence, Predictive Factors, and Impact on Survival

D. Samuel, C. Féray, E. Vibert, 2022, Transplantation.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

New perspectives for preventing hepatitis C virus liver graft infection

R. Chung, D. Samuel, T. Baumert, 2016, The Lancet. Infectious diseases.

Metabolism dysregulation induces a specific lipid signature of nonalcoholic steatohepatitis in patients

D. Samuel, P. Gual, J. Bertrand-Michel, 2017, Scientific Reports.

NON-INVASIVE DIAGNOSIS AND FOLLOW-UP IN LIVER TRANSPLANTATION.

V. de Lédinghen, J. Dumortier, N. Ganne-Carrié, 2021, Clinics and research in hepatology and gastroenterology.

Safety and efficacy of protease inhibitors to treat hepatitis C after liver transplantation: a multicenter experience.

D. Samuel, J. Dumortier, O. Guillaud, 2014, Journal of hepatology.

2020 position statement and recommendations of the European Liver and Intestine Transplantation Association (ELITA): management of hepatitis B virus‐related infection before and after liver transplantation

M. Buti, P. Cortesi, F. Zoulim, 2021, Alimentary pharmacology & therapeutics.

Economic Impact of European Liver and Intestine Transplantation Association (ELITA) Recommendations for Hepatitis B Prophylaxis After Liver Transplantation

M. Buti, P. Cortesi, L. Mantovani, 2023, Transplant International.

Management of post transplant hepatitis C in the direct antiviral agents era

D. Samuel, B. Roche, A. Coilly, 2015, Hepatology International.

G15 : The association of sofosbuvir and daclatasvir for treating severe recurrence of HCV infection after liver transplantation: Results from a large french prospective multicentric ANRS CO23 CUPILT cohort

J. Dumortier, R. Anty, C. Duvoux, 2015 .

Fibrosing Cholestatic Hepatitis in HIV/HCV Co‐Infected Transplant Patients—Usefulness of Early Markers After Liver Transplantation

D. Samuel, B. Roche, A. Coilly, 2011, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.

D. Samuel, J. Dumortier, C. Cagnot, 2022, Clinics and research in hepatology and gastroenterology.

Ribavirin for Hepatitis E Virus Infection After Organ Transplantation: A Large European Retrospective Multicenter Study.

J. Dumortier, J. Izopet, R. D. de Man, 2019, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Delisting of liver transplant candidates with chronic hepatitis C after viral eradication: A European study.

R. Facchetti, P. Cortesi, M. Strazzabosco, 2016, Journal of hepatology.

Kaposi Sarcoma in HIV-positive Solid-Organ Transplant Recipients: A French Multicentric National Study and Literature Review

C. Lebbé, D. Glotz, A. Coilly, 2019, Transplantation.

High trough levels of everolimus combined to sorafenib improve patients survival after hepatocellular carcinoma recurrence in liver transplant recipients

D. Samuel, H. Baba, F. Saliba, 2021, Transplant international : official journal of the European Society for Organ Transplantation.

Characterization of liver injury induced by cancer immunotherapy using immune checkpoint inhibitors.

D. Samuel, C. Robert, O. Lambotte, 2018, Journal of hepatology.

Keep watch for the appearing mushroom!

A. Coilly, 2012, Clinics and research in hepatology and gastroenterology.

Analysis of Liver Resection Versus Liver Transplantation on Outcome of Small Intrahepatic Cholangiocarcinoma and Combined Hepatocellular‐Cholangiocarcinoma in the Setting of Cirrhosis

D. Samuel, K. Boudjema, V. Gnemmi, 2020, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

12 Weeks of a Ribavirin‐Free Sofosbuvir and Nonstructural Protein 5A Inhibitor Regimen Is Enough to Treat Recurrence of Hepatitis C After Liver Transplantation

J. Dumortier, C. Cagnot, A. Tran, 2018, Hepatology.

Management of patients with liver diseases on the waiting list for transplantation: a major impact to the success of liver transplantation

D. Samuel, A. Coilly, 2018, BMC Medicine.

Liver transplantation in patients with liver failure related to exertional heatstroke.

D. Samuel, F. Saliba, M. Boutonnet, 2019, Journal of hepatology.

Paediatric acute liver failure: Confirm the outbreak, find the cause and explore the mechanisms

D. Samuel, A. Coilly, 2022, United European gastroenterology journal.

Post–Liver Transplantation Sinusoidal Obstruction Syndrome With Refractory Ascites Induced by Mycophenolate Mofetil

D. Samuel, H. Bismuth, C. Féray, 2020, Hepatology.

Investigation of Inherited Chromosomally Integrated Human Herpesvirus-6A+ and -6B+ in a Patient with Ulipristal Acetate-Induced Fulminant Hepatic Failure

C. Deback, A. Coilly, T. Antonini, 2021, Viruses.

Donor HLA class 1 evolutionary divergence is a major predictor of liver allograft rejection: a retrospective cohort study

D. Samuel, C. Féray, F. Saliba, 2020, medRxiv.

Cutting out the roots of acute hepatitis C.

D. Samuel, A. Coilly, 2017, The Lancet. Infectious diseases.

The impact of treatment of hepatitis C with DAAs on the occurrence of HCC

D. Samuel, B. Roche, A. Coilly, 2018, Liver international : official journal of the International Association for the Study of the Liver.

Recent Insights into Treatment of Non-Alcoholic Steatohepatitis

A. Coilly, F. Chiappini, Franck Chiappini, 2016 .

Idiopathic Post Liver-Transplant Hepatitis Remains Obscure with Respect to Its Etiology and Relationship with Immunosuppressiona

D. Samuel, E. Ballot, F. Saliba, 2015 .

Reply to: "Frequent plasma cell hepatitis during telaprevir-based triple therapy for hepatitis C after liver transplantation".

A. Coilly, M. Sebagh, J. Duclos‐Vallée, 2014, Journal of hepatology.

Practical Management of Boceprevir and Immunosuppressive Therapy in Liver Transplant Recipients with Hepatitis C Virus Recurrence

D. Samuel, B. Roche, A. Coilly, 2012, Antimicrobial Agents and Chemotherapy.

DHEA and progesterone have a protective effect on ribavirin-induced hemolysis

A. Coilly, M. Sebagh, J. Duclos‐Vallée, 2014 .

Budd-Chiari syndrome.

V. Vilgrain, P. Potier, D. Valla, 2020, Clinics and research in hepatology and gastroenterology.

Sofosbuvir-Based Regimens in HIV/HCV Coinfected Patients After Liver Transplantation: Results From the ANRS CO23 CUPILT Study

V. de Lédinghen, D. Samuel, J. Dumortier, 2018, Transplantation.

Direct‐acting antiviral agent–based regimen for HCV recurrence after combined liver‐kidney transplantation: Results from the ANRS CO23 CUPILT study

V. de Lédinghen, D. Samuel, J. Dumortier, 2017, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

Therapy with boceprevir or telaprevir in HIV/hepatitis C virus co-infected patients to treat recurrence of hepatitis C virus infection after liver transplantation

D. Samuel, A. Coilly, D. Vittecoq, 2015, AIDS.

Optimal therapy in hepatitis C virus liver transplant patients with direct acting antivirals

D. Samuel, B. Roche, A. Coilly, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Once‐daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations

J. Dumortier, O. Guillaud, C. Duvoux, 2015, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.

D. Samuel, A. Coilly, P. Ichai, 2015, Journal of hepatology.

Early liver transplantation for corticosteroid non-responders in acute severe autoimmune hepatitis: the SURFASA score.

V. de Lédinghen, P. Potier, D. Samuel, 2021, Journal of hepatology.

Liver transplantation for patients with acute-on-chronic liver failure (ACLF) in Europe: results of the ELITA/EF-CLIF collaborative study (ECLIS).

P. Cortesi, R. Fumagalli, K. Zieniewicz, 2021, Journal of hepatology.

Proceedings of Réanimation 2017, the French Intensive Care Society International Congress

K. Tarte, G. Le Roux, D. Boels, 2017, Annals of Intensive Care.

A new definition of sarcopenia in patients with cirrhosis undergoing liver transplantation

D. Samuel, E. Vibert, P. Bucur, 2016, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

Very prolonged liposomal amphotericin B use leading to a lysosomal storage disease.

O. Lambotte, O. Lortholary, S. Blanche, 2014, International journal of antimicrobial agents.

Assessment of Malnutrition, Sarcopenia and Frailty in Patients with Cirrhosis: Which Tools Should We Use in Clinical Practice?

Y. Boirie, L. Cassagnes, A. Coilly, 2020, Nutrients.

International Liver Transplantation Consensus Statement on End-stage Liver Disease Due to Nonalcoholic Steatohepatitis and Liver Transplantation.

E. Tsochatzis, A. Coilly, S. Nadalin, 2019, Transplantation.

Liver transplantation in the most severely ill cirrhotic patients: A multicenter study in acute-on-chronic liver failure grade 3.

S. Jaber, D. Samuel, A. Duhamel, 2017, Journal of hepatology.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Management of Transplant Patients Infected with HCV

D. Samuel, B. Roche, A. Coilly, 2021 .

Hepatic Arteriovenous Malformation: The Search for a PTEN Mutation!

D. Samuel, M. Eyries, C. Féray, 2021, Hepatology.

Management of HCV transplant patients with triple therapy

D. Samuel, B. Roche, A. Coilly, 2014, Liver international : official journal of the International Association for the Study of the Liver.

O62 SOFOSBUVIR COMPASSIONATE USE PROGRAM FOR PATIENTS WITH SEVERE RECURRENT HEPATITIS C INCLUDING FIBROSING CHOLESTATIC HEPATITIS FOLLOWING LIVER TRANSPLANTATION

R. Fontana, X. Forns, T. Baumert, 2014 .

Body composition and short-term mortality in patients critically ill with acute-on-chronic liver failure

F. Becce, J. Chiche, D. Moradpour, 2023, JHEP reports : innovation in hepatology.

Impact of negative air pressure in ICU rooms on the risk of pulmonary aspergillosis in COVID-19 patients

D. Samuel, F. Saliba, A. Coilly, 2020, Critical Care.

Risk factors of de novo malignancies after liver transplantation: a French national study on 11004 adult patients.

D. Samuel, G. Launoy, K. Boudjema, 2021, Clinics and research in hepatology and gastroenterology.

Rare predicted loss-of-function variants of type I IFN immunity genes are associated with life-threatening COVID-19

Andrew J. Oler, Eglantine Ferrand Devouge, P. Gregersen, 2023, Genome Medicine.

Covid-19 in liver transplant recipients: the French SOT COVID registry

J. Dumortier, F. Durand, C. Duvoux, 2021, Clinics and Research in Hepatology and Gastroenterology.

COVID-19 in liver transplant candidates: pretransplant and post-transplant outcomes - an ELITA/ELTR multicentre cohort study

R. Facchetti, P. Cortesi, K. Zieniewicz, 2021, Gut.

Liver stiffness-based model predicts hepatic venous pressure gradient in patients with liver disease.

D. Samuel, E. Vibert, A. Coilly, 2021, HPB : the official journal of the International Hepato Pancreato Biliary Association.

Liver stiffness measurement by transient elastography predicts late posthepatectomy outcomes in patients undergoing resection for hepatocellular carcinoma

D. Samuel, E. Vibert, A. Coilly, 2017, Surgery.

Hepatitis E infection in patients with severe acute alcoholic hepatitis

D. Samuel, F. Saliba, B. Roche, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis

V. de Lédinghen, J. Zucman‐Rossi, M. Ronot, 2021, JHEP reports : innovation in hepatology.

Patients Treated for HCV Infection and Listed for Liver Transplantation in a French Multicenter Study: What Happens at Five Years?

V. de Lédinghen, D. Samuel, R. Anty, 2022, Viruses.

Selection and Evaluation of the Recipient (Including Retransplantation)

D. Samuel, A. Coilly, 2012 .

Inevitability of disease recurrence after liver transplantation for NAFLD cirrhosis

D. Samuel, K. Boudjema, C. Duvoux, 2023, JHEP reports : innovation in hepatology.

Disease recurrence after liver transplantation for NAFLD cirrhosis is ineluctable

D. Samuel, K. Boudjema, C. Duvoux, 2023, JHEP Reports.

Diagnosis and management of hepatic encephalopathy: The French recommendations

V. de Lédinghen, D. Galanaud, M. Rudler, 2023, Liver international : official journal of the International Association for the Study of the Liver.

Renal Dysfunction in Liver Transplant Patients Treated with Sofosbuvir Based-Regimen for HCV Recurrence: Results from a Large French Prospective Multicentric ANRS CO23 Cupilt

J. Dumortier, F. Durand, A. Tran, 2016 .

Question and Answer Session on the role of DAA in Transplant Medicine : USA perspective

A. Coilly, A. Yosry, 2016 .

HCV and HEV recurrence after liver transplantation: one antiviral therapy for two viruses

D. Samuel, E. Vibert, A. Coilly, 2017, Transplant international : official journal of the European Society for Organ Transplantation.

Infectious complications after liver transplantation in human immunodeficiency virus‐infected recipients

D. Samuel, O. Lambotte, A. Coilly, 2015, Transplant infectious disease : an official journal of the Transplantation Society.

Treatment and prognosis of acute severe autoimmune hepatitis

M. Rudler, P. Potier, D. Samuel, 2017 .

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence after liver transplantation - The CO23 ANRS CUPILT study.

Leroy, D. Samuel, J. Dumortier, 2016 .

Impact of direct antiviral agents for hepatitis c virus -induced liver diseases on registration, waiting list and liver transplant activity in France.

C. Duvoux, N. Kamar, F. Conti, 2023, Clinics And Research in Hepatology and Gastroenterology.

P0837 : Efficacy of sofosbuvir and daclatasvir in HIV/HCV co-infected patients with advanced fibrosis

D. Samuel, A. Coilly, D. Vittecoq, 2015 .

P0804 : Efficacy of sofosbuvir-based treatment regimens in HIV/HCV co-infected patients after liver transplantation: The ANRS CO23 CUPILT study

D. Samuel, J. Dumortier, N. Kamar, 2015 .

Liver metastases from meningeal hemangiopericytoma

D. Samuel, A. Coilly, C. Guettier, 2015, Liver international : official journal of the International Association for the Study of the Liver.

Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study

R. Facchetti, P. Cortesi, M. Strazzabosco, 2017 .

47 EFFICACY AND SAFETY OF PROTEASE INHIBITORS FOR SEVERE HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A FIRST MULTICENTRIC EXPERIENCE

D. Samuel, B. Roche, A. Coilly, 2012 .

Posttransplantation hepatitis E: transfusion-transmitted hepatitis rising from the ashes.

A. Becq, D. Samuel, B. Roche, 2013, Transplantation.

Parvovirus B19 infection: A challenging cause of fulminant hepatitis.

M. Rudler, D. Thabut, D. Samuel, 2020, Clinics and research in hepatology and gastroenterology.

1422 END OF TREATMENT RESPONSE AFTER PROTEASE INHIBITOR (PI)- BASED THERAPY FOR HEPATITIS C RECURRENCE AFTER LIVER TRANSPLANTATION: A MULTICENTRIC EUROPEAN EXPERIENCE

D. Samuel, J. Dumortier, F. Durand, 2013 .

Liver transplantation for hepatitis C virus in the era of direct-acting antiviral agents.

R. Bruno, A. Coilly, 2015, Current opinion in HIV and AIDS.

Hepatitis E Virus Infection in Patients with Chronic Inflammatory Bowel Disease Treated with Immunosuppressive Therapy

C. Renou, A. Coilly, A. Roque-Afonso, 2023, Pathogens.

Lengthy Follow-up After Liver Transplantation for Nodular Regenerative Hyperplasia in Human Immunodeficiency Virus–Infected Patients: Does the Disease Recur?

D. Samuel, B. Roche, A. Coilly, 2013, Transplantation.

Evidence for Alloimmune Sinusoidal Injury in De Novo Nodular Regenerative Hyperplasia After Liver Transplantation

D. Samuel, C. Féray, F. Saliba, 2023, Transplant international : official journal of the European Society for Organ Transplantation.

Pros and Cons: Usage of organs from donors infected with hepatitis C virus - Revision in the direct-acting antiviral era.

D. Samuel, A. Coilly, 2016, Journal of hepatology.

Bile salts control the antimicrobial peptide cathelicidin through nuclear receptors in the human biliary epithelium.

D. Wendum, C. Corpechot, R. Poupon, 2009, Gastroenterology.

Sofosbuvir‐based treatment of hepatitis C with severe fibrosis (METAVIR F3/F4) after liver transplantation

The role of corticosteroids in acute-severe autoimmune hepatitis is still highly debatable.

D. Samuel, A. Coilly, P. Ichai, 2015, Journal of hepatology.

Comparison of the effect of direct-acting antiviral with and without ribavirin on cyclosporine and tacrolimus clearance values: results from the ANRS CO23 CUPILT cohort

V. de Lédinghen, D. Samuel, F. Durand, 2019, European Journal of Clinical Pharmacology.

Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)

V. de Lédinghen, J. Zucman‐Rossi, D. Thabut, 2023, Quality of Life Research.

Efficiency and safety of total plasma exchange in critically ill cirrhotic patients with acute on chronic liver failure: a pilot study.

F. Saliba, A. Coilly, R. Sobesky, 2023, Clinics and research in hepatology and gastroenterology.

Identification of liver transplant biopsy phenotypes associated with distinct liver biological markers and allograft survival.

A. Loupy, C. Féray, M. Raynaud, 2023, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Multicentre experience using daclatasvir and sofosbuvir to treat hepatitis C recurrence - The ANRS CUPILT study.

V. de Lédinghen, D. Samuel, J. Dumortier, 2016, Journal of hepatology.

219 PROSPECTIVE ASSESSMENT OF LIVER FIBROSIS AFTER LIVER TRANSPLANTATION IN HIV/HCV COINFECTED PATIENTS: A USEFUL TOOL ASSESSING SEVERE FIBROSIS ON THE LIVER GRAFT

D. Samuel, B. Roche, A. Coilly, 2012 .

Once‐daily prolonged release tacrolimus in liver transplantation: Experts' literature review and recommendations

Long-term outcome following liver transplantation of patients with ACLF grade 3.

A. Coilly, G. Pageaux, E. Boleslawski, 2024, Journal of hepatology.

Liver transplant selection criteria and outcomes in critically ill patients with ACLF

C. Féray, F. Saliba, A. Coilly, 2023, JHEP reports : innovation in hepatology.

Long-term outcome following liver transplantation for patients with acute on chronic liver failure grade 3 (ACLF-3): a retrospective matched-controlled study

D. Samuel, F. Saliba, E. Vibert, 2023, Journal of Hepatology.

Clinical application of infrared spectroscopy in liver transplantation for rapid assessment of lipid content in liver graft.

S. Kascakova, A. Coilly, F. Le Naour, 2024, Laboratory investigation; a journal of technical methods and pathology.

Impact of HLA divergence on humoral response to SARS-CoV-2 and HBV vaccines in the liver transplantation setting

D. Samuel, C. Féray, B. Roche, 2022, medRxiv.

Donor HLA Class 1 Evolutionary Divergence Is a Major Predictor of Liver Allograft Rejection

C. Féray, F. Saliba, A. Coilly, 2021, Annals of Internal Medicine.

HCV treatment in cirrhotic patients: Should we use a different approach for patients with a liver transplant perspective?

A. Coilly, G. Pageaux, L. Meunier, 2020, Journal of hepatology.